GB1445740A - Ethanolamine derivatives - Google Patents

Ethanolamine derivatives

Info

Publication number
GB1445740A
GB1445740A GB5834473A GB5834473A GB1445740A GB 1445740 A GB1445740 A GB 1445740A GB 5834473 A GB5834473 A GB 5834473A GB 5834473 A GB5834473 A GB 5834473A GB 1445740 A GB1445740 A GB 1445740A
Authority
GB
United Kingdom
Prior art keywords
compounds
action
groups
novel
hydroxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5834473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2261914A external-priority patent/DE2261914C3/de
Priority claimed from DE19732345442 external-priority patent/DE2345442C2/de
Priority claimed from DE19732351281 external-priority patent/DE2351281C3/de
Priority claimed from DE2354961A external-priority patent/DE2354961C2/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB1445740A publication Critical patent/GB1445740A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB5834473A 1972-12-18 1973-12-17 Ethanolamine derivatives Expired GB1445740A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2261914A DE2261914C3 (de) 1972-12-18 1972-12-18 Amino-phenyl-äthanolamine und deren Säureadditionssalze, Verfahren zu deren Herstellung und Arzneimittel
DE19732345442 DE2345442C2 (de) 1973-09-08 1973-09-08 d- und l-Phenyläthanolamine und deren Salze, Herstellungsverfahren und Arzneimittel auf deren Basis
DE19732351281 DE2351281C3 (de) 1973-10-12 1973-10-12 Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
DE2354961A DE2354961C2 (de) 1973-11-02 1973-11-02 Verfahren zur Herstellung von Aminophenyl-äthanolaminen

Publications (1)

Publication Number Publication Date
GB1445740A true GB1445740A (en) 1976-08-11

Family

ID=27431596

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5834473A Expired GB1445740A (en) 1972-12-18 1973-12-17 Ethanolamine derivatives

Country Status (20)

Country Link
JP (1) JPS5811852B2 (US07534539-20090519-C00452.png)
KR (1) KR850001916B1 (US07534539-20090519-C00452.png)
BG (1) BG21209A3 (US07534539-20090519-C00452.png)
CA (1) CA1027955A (US07534539-20090519-C00452.png)
CH (2) CH605622A5 (US07534539-20090519-C00452.png)
DD (1) DD111574A5 (US07534539-20090519-C00452.png)
DK (1) DK150502C (US07534539-20090519-C00452.png)
FI (1) FI62052C (US07534539-20090519-C00452.png)
FR (1) FR2210414B1 (US07534539-20090519-C00452.png)
GB (1) GB1445740A (US07534539-20090519-C00452.png)
HK (1) HK6680A (US07534539-20090519-C00452.png)
HU (1) HU168701B (US07534539-20090519-C00452.png)
IE (1) IE39065B1 (US07534539-20090519-C00452.png)
IL (1) IL43837A (US07534539-20090519-C00452.png)
MY (1) MY8800145A (US07534539-20090519-C00452.png)
NL (1) NL176168C (US07534539-20090519-C00452.png)
NO (1) NO137782C (US07534539-20090519-C00452.png)
PL (1) PL97194B1 (US07534539-20090519-C00452.png)
RO (1) RO63025A (US07534539-20090519-C00452.png)
SE (1) SE409700B (US07534539-20090519-C00452.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278727A2 (en) * 1987-02-10 1988-08-17 Glaxo Group Limited 1-(4-Amino-3-chloro-5-trifluoromethylphenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease
US4921867A (en) * 1987-02-10 1990-05-01 Glaxo Group Limited Pyridine compounds useful for therapy or prophylaxis of a disease associated with airway obstruction
US4937251A (en) * 1986-02-12 1990-06-26 Glaxo Group Limited Dichloroaniline compounds useful for method of therapy or prophylaxis of a disease associated with reversible airway obstruction

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430486A1 (fr) * 1978-07-07 1980-02-01 Oreal Conditionnement d'un produit desinfectant et desodorisant pour cuvette de toilettes
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
FR2515177A1 (fr) * 1981-10-28 1983-04-29 Lafon Labor Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4943591A (en) * 1984-10-17 1990-07-24 Glaxo Group Limited Dichloroaniline derivatives
US4863959A (en) * 1985-10-17 1989-09-05 American Cyanamid Company Anthranilonitrile derivatives as useful agents for promoting growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals
ATE61794T1 (de) * 1985-10-17 1991-04-15 American Cyanamid Co Anthranilonitrilderivate und verwandte verbindungen als nuetzliche stoffe zur wachstumsbeschleunigung, zur verbesserung der futterqualitaet und zur steigerung des fleisch/fett-verhaeltnisses bei warmbluetigen tieren.
EP2423188B1 (en) * 2003-08-29 2021-03-10 Mitsui Chemicals Agro, Inc. Intermediates in the preparation of agricultural/horticultural insecticides and method for using the same
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain
CN100497296C (zh) * 2006-07-07 2009-06-10 沈阳药科大学 旋光活性的苯乙醇胺类化合物及其制法
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937251A (en) * 1986-02-12 1990-06-26 Glaxo Group Limited Dichloroaniline compounds useful for method of therapy or prophylaxis of a disease associated with reversible airway obstruction
EP0278727A2 (en) * 1987-02-10 1988-08-17 Glaxo Group Limited 1-(4-Amino-3-chloro-5-trifluoromethylphenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease
EP0278727A3 (en) * 1987-02-10 1990-03-14 Glaxo Group Limited 1-(4-amino-3-chloro-5-trifluoromethylphenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease
US4921867A (en) * 1987-02-10 1990-05-01 Glaxo Group Limited Pyridine compounds useful for therapy or prophylaxis of a disease associated with airway obstruction
US4959381A (en) * 1987-02-10 1990-09-25 Glaxo Group Limited Pyridine compounds which have useful activity associated with reversible air ways obstruction

Also Published As

Publication number Publication date
HK6680A (en) 1980-03-07
RO63025A (fr) 1978-12-15
JPS4994640A (US07534539-20090519-C00452.png) 1974-09-09
IE39065B1 (en) 1978-08-02
NO137782C (no) 1978-04-26
CA1027955A (en) 1978-03-14
BG21209A3 (bg) 1976-03-20
DK150502B (da) 1987-03-16
NO137782B (no) 1978-01-16
NL176168B (nl) 1984-10-01
SE409700B (sv) 1979-09-03
IL43837A (en) 1977-02-28
KR830000207A (ko) 1983-03-30
AU6369373A (en) 1975-06-19
NL7316139A (US07534539-20090519-C00452.png) 1974-06-20
DD111574A5 (US07534539-20090519-C00452.png) 1975-02-20
HU168701B (US07534539-20090519-C00452.png) 1976-06-28
FR2210414A1 (US07534539-20090519-C00452.png) 1974-07-12
IL43837A0 (en) 1974-03-14
IE39065L (en) 1974-06-18
FI62052C (fi) 1982-11-10
CH605622A5 (US07534539-20090519-C00452.png) 1978-10-13
NL176168C (nl) 1985-03-01
FI62052B (fi) 1982-07-30
KR850001916B1 (ko) 1985-12-31
DK150502C (da) 1987-10-26
PL97194B1 (pl) 1978-02-28
CH614188A5 (en) 1979-11-15
MY8800145A (en) 1988-12-31
JPS5811852B2 (ja) 1983-03-04
FR2210414B1 (US07534539-20090519-C00452.png) 1977-01-28

Similar Documents

Publication Publication Date Title
GB1445740A (en) Ethanolamine derivatives
PT65697B (pt) Procede pour la preparation de steroides avec des anneaux a 15 atomes de carbone
ES8105696A1 (es) Procedimiento para la preparacion de polieterpoliaminas
ES465523A1 (es) Procedimiento para la obtencion de nuevas feniletilaminas.
ES8202808A1 (es) Un procedimiento para la preparacion de derivados de benzofurano.
ES493922A0 (es) Procedimiento para la preparacion de 4-fenoxipiperidinas
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
ES448175A1 (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2).
IE44765L (en) N-substituted benzamides.
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
ES468630A1 (es) Procedimiento para la obtencion de derivados de la isoquino-leina.
PT76335A (de) Neue basisch substituierte 4-phenyl-4,5,6,7-tetrahydro-thieno-<2,3-c>pyridine verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ES464553A2 (es) Mejoras introducidas en el objeto de la patente principal por procedimiento para la preparacion de anilidas de acido 5-metil-isoxazol-4-carboxilico.
KR950000705A (ko) 14-치환 몰피난 유도체 및 이를 함유하는 의약
KR910000691A (ko) 간질치료제로서의 5-페닐-2-푸란 케톤의 용도
ES456639A1 (es) Un procedimiento de preparacion de los derivados del ciclo- penta (b) tiofeno.
ES410668A2 (es) Un procedimiento para la preparacion de composiciones her- bicidas a base de derivados de aminoacido n,n-disustituidos.
ATE139780T1 (de) Amidderivate von 1-amino-octahydropyrido(2,1- c>(1,4>oxazin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES474955A1 (es) Un procedimiento para la preparacion de un compuesto polici-clico
IE45779L (en) Novel anhydro-sugars and a process for their preparation
ES425795A1 (es) Procedimiento para la preparacion de nuevas amino-fenil- etanolaminas. fenil-e- tanolaminas.
ES464182A1 (es) Procedimiento de preparacion de acidos aril-alifativos sus- tituidos.
ES8102144A2 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19931216